Damage-Associated Molecular Patterns and Pattern Recognition Receptors in the Podocyte.


Journal

Journal of the American Society of Nephrology : JASN
ISSN: 1533-3450
Titre abrégé: J Am Soc Nephrol
Pays: United States
ID NLM: 9013836

Informations de publication

Date de publication:
27 Sep 2024
Historique:
received: 31 05 2024
accepted: 24 09 2024
medline: 27 9 2024
pubmed: 27 9 2024
entrez: 27 9 2024
Statut: aheadofprint

Résumé

Podocytes possess immune system components allowing for a variety of innate responses to endogenous and exogenous stimuli. Recently, several groups have linked inappropriate innate immune signaling to podocyte injury, particularly chronic, sustained injury; however, the immune capabilities of podocytes have not been fully elucidated. Damage associated molecular patterns (DAMPs) are endogenous danger molecules released from damaged cells, including podocytes, and can elicit an inflammatory response and recruit immune cells to areas of injury. This is done through binding to pattern recognition receptors (PRR). Thought largely to be protective and responsive to injury or infection, recent evidence suggests signaling via DAMP pathways can aggravate and promote chronic diseases already associated with inflammation. The purpose of this narrative review is to highlight current knowledge with respect to specific podocyte DAMPs and PRRs, and to provide insight into ongoing work and possible future research avenues to advance our understanding of podocyte immune mechanisms.

Identifiants

pubmed: 39331471
doi: 10.1681/ASN.0000000531
pii: 00001751-990000000-00429
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 by the American Society of Nephrology.

Auteurs

Robert L Myette (RL)

Children's Hospital of Eastern Ontario, Division of Pediatric Nephrology, University of Ottawa, Ottawa, Ontario, Canada.
Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Kidney Research Center, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Mayra Trentin-Sonoda (M)

Kidney Research Center, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Chloé Landry (C)

Kidney Research Center, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Chet E Holterman (CE)

Kidney Research Center, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Tony Lin (T)

Kidney Research Center, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Dylan Burger (D)

Kidney Research Center, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Christopher R J Kennedy (CRJ)

Kidney Research Center, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Classifications MeSH